WONMI LEE: Open Payments
NPI 1225742984 · PERRY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 32 payments from 11 companies in 2025. Trend: 2023 $566 · 2024 $631 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $114 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Amgen Inc. | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 4 | $48 |
| ABBVIE INC. | 2 | $47 |
| PFIZER INC. | 2 | $43 |
| Exact Sciences Corporation | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
Products named: Ozempic, LEQVIO, VOQUEZNA, AIRSUPRA, VRAYLAR, The Cologuard Plus Collection Kit, Rybelsus, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
